Skip to main content

Silexion Therapeutics Corp

SLXNW
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0002022416

No open-market purchases or sales by Silexion Therapeutics Corp insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $98.7K in total; no superinvestor holds it.

Other share classesSLXN

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, 0 vs. previous quarter
19
13F valueReported value at the end of Q2 2026
$98.7K
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding SLXNW, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding SLXNW at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Silexion Therapeutics Corp insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 30, 2026 (view filing)Mar 264 daysShirvan MitchellCSO and CDOSSale−22.8K$1.36−$31.0K−45.0%27.9K after

Top 10 13F holders, Q2 2026

The largest institutional positions in Silexion Therapeutics Corp at the end of Q2 2026; share changes are against Q1 2026.

See all 19 holders
Institutions holding SLXNW in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Oasis Management Co Ltd.11,111$28.3K0.00%00.0%Unchanged
Polar Asset Management Partners Inc.743,475$20.8K0.00%00.0%Unchanged
Linden Advisors LP337,500$9.48K0.00%00.0%Unchanged
Aristeia Capital LLC236,546$6.63K0.00%00.0%Unchanged
Clear Street Group Inc.218,165$6.63K0.00%−600−0.3%Reduced
Security Benefit Life Insurance Co150,000$4.56K0.00%00.0%Unchanged
Goldman Sachs Group Inc125,103$3.80K0.00%+1,609+1.3%Added
Kepos Capital LP100,000$3.00K0.00%00.0%Unchanged
Susquehanna International Group, LLP92,073$2.80K0.00%+92,073New
Jane Street Group, LLC74,910$2.28K0.00%00.0%Unchanged